258 related articles for article (PubMed ID: 8870895)
1. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
[TBL] [Abstract][Full Text] [Related]
2. Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Oct; 53(19):2304-9. PubMed ID: 8893069
[TBL] [Abstract][Full Text] [Related]
3. Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Aug; 53(16):1944-9. PubMed ID: 8862208
[TBL] [Abstract][Full Text] [Related]
4. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
[TBL] [Abstract][Full Text] [Related]
5. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Sep; 53(18):2179-84. PubMed ID: 8879325
[TBL] [Abstract][Full Text] [Related]
6. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1998 Sep; 55(18):1915-20. PubMed ID: 9784772
[TBL] [Abstract][Full Text] [Related]
7. Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.
Metras JI; Swenson CF; McDermott MP
Am J Hosp Pharm; 1992 Jul; 49(7):1720-4. PubMed ID: 1621730
[TBL] [Abstract][Full Text] [Related]
8. Stability of rifabutin in two extemporaneously compounded oral liquids.
Haslam JL; Egodage KL; Chen Y; Rajewski RA; Stella V
Am J Health Syst Pharm; 1999 Feb; 56(4):333-6. PubMed ID: 10690216
[TBL] [Abstract][Full Text] [Related]
9. Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids.
Fish DN; Vidaurri VA; Deeter RG
Am J Health Syst Pharm; 1999 Oct; 56(19):1957-60. PubMed ID: 10554914
[TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneously prepared moxifloxacin oral suspensions.
Hutchinson DJ; Johnson CE; Klein KC
Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
[TBL] [Abstract][Full Text] [Related]
11. Stability of ganciclovir in extemporaneously compounded oral liquids.
Anaizi NH; Swenson CF; Dentinger PJ
Am J Health Syst Pharm; 1999 Sep; 56(17):1738-41. PubMed ID: 10512505
[TBL] [Abstract][Full Text] [Related]
12. Stability of sotalol in two liquid formulations at two temperatures.
Nahata MC; Morosco RS
Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
[TBL] [Abstract][Full Text] [Related]
13. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP; Johnson CE; Sudekum D; Penprase K
Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
[TBL] [Abstract][Full Text] [Related]
14. Stability of extemporaneously prepared cinacalcet oral suspensions.
Thomson K; Hutchinson DJ; Chablani L
Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
[TBL] [Abstract][Full Text] [Related]
15. Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP; Johnson CE; Lee J; Currie K
Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
[TBL] [Abstract][Full Text] [Related]
16. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
Nahata MC; Morosco RS; Hipple TF
Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
[TBL] [Abstract][Full Text] [Related]
17. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
18. Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
Lin YS; Lin SC; Hsieh YT; Liu LY; Lin CH; Shen LJ; Huang CF
Eur J Hosp Pharm; 2022 Nov; 29(6):324-328. PubMed ID: 33608396
[TBL] [Abstract][Full Text] [Related]
19. Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE; Cober MP; Hawkins KA; Julian JD
Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
[TBL] [Abstract][Full Text] [Related]
20. Stability of Adderall in extemporaneously compounded oral liquids.
Justice J; Kupiec TC; Matthews P; Cardona P
Am J Health Syst Pharm; 2001 Aug; 58(15):1418-21. PubMed ID: 11494787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
